Michael D West Age X Therapeutics, Inc. (AGE) insider trading activity

AGE Quotes by TradingView

Michael D West is Chief Executive Officer of AgeX Therapeutics, Inc.. Currently has a direct ownership of 41,982 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2023, when has been sold 1,060 shares (Common Stock, $0.0001 par value) at a price of $0.59 per share, resulting in proceeds of $625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42K
0% 3M change
0% 12M change
Total Value Held $0

MICHAEL D WEST Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2023
SELL
Payment of exercise price or tax liability
$625 $0.59 p/Share
1,060 Reduced 2.46%
41,982 Common Stock, $0.0001 ...
Mar 11 2023
BUY
Exercise of conversion of derivative security
-
3,125 Added 6.77%
43,042 Common Stock, $0.0001 ...
Dec 11 2022
SELL
Payment of exercise price or tax liability
$637 $0.59 p/Share
1,081 Reduced 2.64%
39,917 Common Stock, $0.0001 ...
Dec 11 2022
BUY
Exercise of conversion of derivative security
-
3,125 Added 7.08%
40,998 Common Stock, $0.0001 ...
Sep 11 2022
SELL
Payment of exercise price or tax liability
$605 $0.56 p/Share
1,081 Reduced 2.37%
44,503 Common Stock, $0.0001 ...
Sep 11 2022
BUY
Exercise of conversion of derivative security
-
3,125 Added 6.42%
45,584 Common Stock, $0.0001 ...
Jun 11 2022
SELL
Payment of exercise price or tax liability
$832 $0.77 p/Share
1,081 Reduced 2.48%
42,459 Common Stock, $0.0001 ...
Jun 11 2022
BUY
Exercise of conversion of derivative security
-
3,125 Added 6.7%
43,540 Common Stock, $0.0001 ...
Mar 11 2022
SELL
Payment of exercise price or tax liability
$884 $0.69 p/Share
1,281 Reduced 3.07%
40,415 Common Stock, $0.0001 ...
Mar 11 2022
BUY
Exercise of conversion of derivative security
-
3,125 Added 6.97%
41,696 Common Stock, $0.0001 ...
Dec 11 2021
SELL
Payment of exercise price or tax liability
$692 $0.64 p/Share
1,081 Reduced 2.73%
38,571 Common Stock, $0.0001 ...
Dec 11 2021
BUY
Exercise of conversion of derivative security
-
3,125 Added 7.31%
39,652 Common Stock, $0.0001 ...
Sep 11 2021
SELL
Payment of exercise price or tax liability
$1,081 $1.0 p/Share
1,081 Reduced 2.87%
36,527 Common Stock, $0.0001 ...
Sep 11 2021
BUY
Exercise of conversion of derivative security
-
3,125 Added 7.67%
37,608 Common Stock, $0.0001 ...
Jun 11 2021
SELL
Payment of exercise price or tax liability
$1,654 $1.53 p/Share
1,081 Reduced 3.04%
34,483 Common Stock, $0.0001 ...
Jun 11 2021
BUY
Exercise of conversion of derivative security
-
3,125 Added 8.08%
35,564 Common Stock, $0.0001 ...
Mar 11 2021
SELL
Payment of exercise price or tax liability
$2,607 $2.03 p/Share
1,284 Reduced 3.81%
32,439 Common Stock, $0.0001 ...
Mar 11 2021
BUY
Exercise of conversion of derivative security
-
3,125 Added 8.48%
33,723 Common Stock, $0.0001 ...
Dec 11 2020
SELL
Payment of exercise price or tax liability
$1,827 $1.69 p/Share
1,081 Reduced 3.41%
30,598 Common Stock, $0.0001 ...
Dec 11 2020
BUY
Exercise of conversion of derivative security
-
3,125 Added 8.98%
31,679 Common Stock, $0.0001 ...
MDW

Michael D West

Chief Executive Officer
Alameda, CA

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGE